Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks
LON:SCLP

Scancell 1/30/2025 Earnings Report

Scancell logo
GBX 10.75 +0.25 (+2.38%)
As of 06:06 AM Eastern
ProfileEarnings History

Scancell EPS Results

Actual EPS
-GBX 1.35
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Scancell Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Scancell Announcement Details

Quarter
Date
1/30/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Scancell Earnings Headlines

Scancell Holdings Sees Significant Share Acquisition by Vulpes Testudo Fund
August 4, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/scancell-holdings-sees-significant-share-acquisition-by-vulpes-testudo-fund?utm_source=marketbeat.com&utm_medium=referral
Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody® iSCIB1+
July 23, 2025  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2025/07/22/10226900.htm
This stock could leave NVDA in the dust
Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.tc pixel
 |  InvestorPlace (Ad)
Scancell Hldgs Plc (SCLP)
February 21, 2025  |  uk.investing.comhttps://uk.investing.com/equities/scancell-holdings-plc
Scancell Holdings Grants Share Options to Executive Directors
February 20, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/scancell-holdings-grants-share-options-to-executive-directors?utm_source=marketbeat.com&utm_medium=referral
With 42% stake, Scancell Holdings plc (LON:SCLP) seems to have captured hedge funds investors' interest
January 19, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/42-stake-scancell-holdings-plc-074026965.html
See More Scancell Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Scancell? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Scancell and other key companies, straight to your email.

About Scancell

Scancell (LON:SCLP) (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers. Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs. Our advanced therapeutic vaccine programmes, SCOPE and ModiFY, have shown promising efficacy in Phase 2 trials, demonstrating long-term survival in metastatic melanoma and a broad range of solid tumours.

View Scancell Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles